What it does: Research, develop and manufacture innovative pharmaceutical medicines, vaccines, and consumer healthcare products
Mission: To help people do more, feel better and live longer.
Size & Presence: Currently operating with over 10000 employees spread across our four business entities – Pharmaceuticals & Vaccines, Consumer Healthcare, Business Service Centre and Consumer Healthcare Quality Supply Chain.
Best Known For: Popular prescription medications, vaccines, and consumer health products.
The good bits: Excellent corporate culture, flat structure, impactful work
The not-so-good bits: Complex tools and systems
We are headquartered in Mumbai (Dr Annie Besant Road, Mumbai 400030, Maharashtra, India) with 8 regional and sales hubs across the country. The company has made substantial investments in a large manufacturing facility - Nashik, in the state of Maharashtra.
Inaugurated in 1983, the Nashik factory is situated on 47 acres of land in Ambad industrial belt (A-10, Ambad - Uttam Nagar Rd, MIDC Area, MIDC Ambad, Nashik, Maharashtra 422010, India). The facility manufactures tablets, creams and ointments and has a committed workforce of over 500 people. The site continuously invests in technology, facility & equipment to deliver Safety, Health, Environment & Quality to the global standards of the company. A new state-of-the-art manufacturing facility for Eltroxin is now operational at the site. Also, all the existing facilities are regularly upgraded and maintained by developing indigenous technology/solutions & automating operations, to ensure continuous improvements in productivity and efficiency. The site ensures sustainable operations through technology adoption, energy conservation and environment-friendly processes to manufacture high-quality affordable products. The facility is committed to conserving natural resources and ensuring operational safety in all its processes and has received various accolades in the areas of EHS - operational safety, environment protection, energy and water conservation.
Finding a culture that is right for you is a crucial part of identifying a new role in a company where you can thrive.
Our culture is driven by the performance because we know that if we perform at our best we can fulfil our purpose of helping people do more, feel better and live longer.
We enhance performance by creating an environment of belonging, supporting your health and wellbeing, and encouraging your continuous development. It’s all part of the deal we make with you when you work here - we want you to fulfil your potential and accomplish great things, so we need to support you to do so.
At GSK we focus on what matters most to our people, this means managers helping employees to be themselves, feel good and keep growing, in ways that work for them.
Our people are essential to our success. We focus on building their capabilities and aim to support and empower them to be the best they can be.
Happy, motivated people are key to the success of our business, so we do everything we can to make working here rewarding.
GSK’s people are essential to our success. We need a talented, motivated and resilient workforce if we are to deliver on our strategy and tackle global health challenges effectively. To achieve this, we aim to create a working environment where employees feel valued, respected, empowered and inspired.
As a science-based healthcare company, addressing our environmental impact is fundamental to our purpose, so that together with our partners, we can help protect and restore the planet’s health, in order to protect and improve people’s health.
We have set a goal to have a net positive impact on nature by 2030. Measuring and accounting for how companies impact the natural world is an emerging field. We are collaborating with partners to understand how best to measure our nature impacts and meet industry standards, for example working with the World Business Council of Sustainable Development to contribute to the Science-Based Targets Network for nature.
We will align to the Science-Based Targets Network approach to measure our impact on nature and will seek to accredit our target when the methodology is finalised.
We are committed to deforestation-free sourcing, as defined by the Accountability Framework (AFi), for all key commodities purchased by GSK or indirectly on our behalf. The complexity of our operations and our supply chain makes this an ambitious undertaking requiring a phased approach.
We have identified priority materials that are of strategic importance to our business, and that also have an impact on deforestation. These include paper packaging, palm oil derivatives, and soy and cattle-derived products.
To date, we have focused on developing sourcing standards for paper packaging based on Forest Stewardship Council (FSC) requirements and palm oil derivatives based on principles set by the Roundtable on Sustainable Palm Oil (RSPO). We have implemented responsible sourcing programs for these commodities in conjunction with the Rainforest Alliance. We are members of Action for Sustainable Derivatives (ASD) which works to increase the transparency and traceability of palm oil derivatives in supply chains.
We are committed to working with others to improve our approach to sustainable sourcing across all materials, including finding deforestation-free solutions, and will collaborate with other stakeholders in the supply chain, government, and civil society, as well as contributing to industry activities that focus on improving sustainable sourcing for the healthcare industry.
Our Biopharma business has committed to positive biodiversity at GSK-owned sites by 2030, with all sites to have biodiversity action plans in place by 2025 and investment in programmes that improve habitats, protect species and improve soil or water quality. Specific site-based actions might include tree planting, adding bird boxes on-site and pond maintenance.